Abstract

The sharp increase in the proportion of asymptomatic cases and the potential risk of virus transmission have greatly increased the difficulty of controlling the COVID-19 pandemic. The individual immune response is closely associated with clinical outcomes and pathogenic mechanisms of COVID-19. However, the clinical characteristics and immunophenotyping features of immune cells of asymptomatic individuals remain somewhat mysterious. To better understand and predict the disease state and progress, we performed a comprehensive analysis of clinical data, laboratory indexes and immunophenotyping features in 41 patients with SARS-CoV-2 (including 24 asymptomatic cases and 17 symptomatic individuals). Firstly, from the perspective of demographic characteristics, the rate of asymptomatic infection was significantly higher in those with younger age. Secondly, the laboratory test results showed that some indexes, such as CRP (acute phase reaction protein), D-Dimer and fibrinogen (the marker for coagulation) were lower in the asymptomatic group. Finally, symptomatic individuals were prone to establishing a non-protective immune phenotype by abnormally decreasing the lymphocyte count and percentage, abnormally increasing the Th17 percentage and decreasing Treg percentage, which therefore cause an increase in the neutrophil/lymphocyte ratio (NLR), monocytes/lymphocytes ratio (MLR) and Th17/Treg ratio. On the other hand, asymptomatic individuals tended to establish a more effective and protective immune phenotype by maintaining a normal level of lymphocyte count and percentage and a high level of NK cells. At the same time, asymptomatic individuals can establish a relatively balanced immune response through maintaining a low level of monocytes, a relatively low level of Th17 and high level of Treg, which therefore lead to a decrease in MNKR and Th17/Treg ratio and finally the avoidance of excessive inflammatory responses. This may be one of the reasons for their asymptomatic states. This study is helpful to reveal the immunological characteristics of asymptomatic individuals, understand immune pathogenesis of COVID-19 and predict clinical outcomes more precisely. However, owing to small sample sizes, a future study with larger sample size is still warranted.

Highlights

  • A vast proportion of asymptomatic COVID-19 individuals may cause an exponential increase in the number of COVID-19 cases globally

  • The immune mechanisms that are associated with asymptomatic infection are still largely elusive

  • To reveal possible mechanisms by which a large fraction of COVID-19 patients remain asymptomatic, we aimed to investigate whether the clinical characteristics and immunophenotyping of innate and adaptive immune cells in asymptomatic and symptomatic COVID-19 patients can help us identify pathological or protective immune responses during COVID-19 infection

Read more

Summary

Introduction

In December 2019, the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, broke out in China. August 2021, the WHO reported that there had been 208,470,375 confirmed cases, including. According to Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition) of the National Health Commission of the People’s Republic of China, confirmed cases could be classified into four clinical types: mild cases, moderate cases, severe cases and critical cases [1]. In the early stage of the outbreak, most medical resources tended to identify and treat critical cases. With the discovery of the risk posed by asymptomatic transmission, it is of great significance to pay more attention to asymptomatic individuals to contain outbreaks

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call